Zebrafish as tools for drug discovery

Nature Reviews Drug Discovery

Volumn 14, Issue 10, 2015, Pages 721-731

  MacRae, Calum A ^a,b,c,d   Peterson, Randall T ^c,d,e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD STEM CELL INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOTHIOPHENE; DORSOMORPHIN; ENZYME; GLUCOCORTICOID; PROHEMA; PROSTAGLANDIN E2 DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN; PROTO 1; RECEPTOR; UNCLASSIFIED DRUG; (6-(4-(2-PIPERIDIN-1-YLETHOXY)PHENYL))-3-PYRIDIN-4-YLPYRAZOLO(1,5-A)PYRIMIDINE; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ACUTE MYELOBLASTIC LEUKEMIA; AFFINITY CHROMATOGRAPHY; BIOLOGY; CARDIOTOXICITY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EXCRETION; DRUG METABOLISM; GENETIC ENGINEERING; LIVER TOXICITY; LONG QT SYNDROME; NEPHROTOXICITY; NONHUMAN; PHENOTYPE; PHYSIOLOGY; PRIORITY JOURNAL; REPOLARIZATION TOXICITY; REPRODUCTIVE TOXICITY; REVIEW; SCREENING; TOXICITY; ZEBRA FISH; ANIMAL; ANIMAL EMBRYO; ANIMAL MODEL; DRUG DEVELOPMENT; DRUG EFFECTS; DRUG SCREENING; EMBRYOLOGY; HUMAN;

ANIMALS; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; EMBRYO, NONMAMMALIAN; HUMANS; MODELS, ANIMAL; PYRAZOLES; PYRIMIDINES; ZEBRAFISH;

EID: 84942987418     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd4627     Document Type: Review

References (106)

1. Swinney, D. C. & Anthony, J. How were new medicines discovered? Nat. Rev. Drug Discov. 10, 507-519 (2011).
2. Clader, J. W. The discovery of ezetimibe: a view from outside the receptor. J. Med. Chem. 47, 1-9 (2004).
3. Stitziel, N. O. et al. Inactivating mutations in NPC1L1 and protection from coronary heart disease. N. Engl. J. Med. 371, 2072-2082 (2014).
4. Kodama, I., Kamiya, K. & Toyama, J. Cellular electro-pharmacology of amiodarone. Cardiovasc. Res. 35, 13-29 (1997).
5. Path, G. J., Dai, X. Z., Schwartz, J. S., Benditt, D. G. & Bache, R. J. Effects of amiodarone with and without polysorbate 80 on myocardial oxygen consumption and coronary blood flow during treadmill exercise in the dog. J. Cardiovasc. Pharmacol. 18, 11-16 (1991).
6. Li, Z. H. et al. Combined in vivo imaging and omics approaches reveal metabolism of icaritin and its glycosides in zebrafish larvae. Mol. Biosyst. 7, 2128-2138 (2011).
7. Jeong, J. Y. et al. Functional and developmental analysis of the blood-brain barrier in zebrafish. Brain Res. Bull. 75, 619-628 (2008).
8. Goldstone, J. V. et al. Identification and developmental expression of the full complement ofcytochrome P450 genes in zebrafish. BMC Genomics 11, 643 (2010).
9. Seok, J. et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl Acad. Sci. USA 110, 3507-3512 (2013).
10. Howe, K. et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature 496, 498-503 (2013).
11. Tiso, N., Moro, E. & Argenton, F. Zebrafish pancreas development. Mol. Cell. Endocrinol. 312, 24-30 (2009).
12. Gut, P. et al. Whole-organism screening for gluconeogenesis identifies activators of fasting metabolism. Nat. Chem. Biol. 9, 97-104 (2013).
13. Jagannathan-Bogdan, M. & Zon, L. I. Hematopoiesis. Development 140, 2463-2467 (2013).
14. Ganis, J. J. et al. Zebrafish globin switching occurs in two developmental stages and is controlled by the LCR. Dev. Biol. 366, 185-194 (2012).
15. Steinbicker, A. U. et al. Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. Blood 117, 4915-4923 (2011).
16. Donovan, A. et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403, 776-781 (2000).
17. Paffett-Lugassy, N. et al. Functional conservation of erythropoietin signaling in zebrafish. Blood 110, 2718-2726 (2007).
18. Asnani, A. & Peterson, R. T. The zebrafish as a tool to identify novel therapies for human cardiovascular disease. Dis. Model. Mech. 7, 763-767 (2014).
19. Milan, D. J., Peterson, T. A., Ruskin, J. N., Peterson, R. T. & MacRae, C. A. Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation 107, 1355-1358 (2003).
20. Burns, C. G. et al. High-throughput assay for small molecules that modulate zebrafish embryonic heart rate. Nat. Chem. Biol. 1, 263-264 (2005).
21. Chi, N. C. et al. Genetic and physiologic dissection of the vertebrate cardiac conduction system. PLoS Biol. 6, e109 (2008).
22. Milan, D. J., Giokas, A. C., Serluca, F. C., Peterson, R. T. & MacRae, C. A. Notch1b and neuregulin are required for specification of central cardiac conduction tissue. Development 133, 1125-1132 (2006).
23. Milan, D. J., Jones, I. L., Ellinor, P. T. & MacRae, C. A. In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation. Am. J. Physiol. Heart Circ. Physiol. 291, H269-H273 (2006).
24. Schwerte, T. & Pelster, B. Digital motion analysis as a tool for analysing the shape and performance of the circulatory system in transparent animals. J. Exp. Biol. 203, 1659-1669 (2000).
25. Yu, P. B. et al. BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat. Med. 14, 1363-1369 (2008).
26. Ren, B. et al. ERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish. J. Clin. Invest. 120, 1217-1228 (2010).
27. Zhang, Y. et al. AML1-ETO mediates hematopoietic self-renewal and leukemogenesis through a COX/β-catenin signaling pathway. Blood 121, 4906-4916 (2013).
28. Kokel, D. et al. Photochemical activation of TRPA1 channels in neurons and animals. Nat. Chem. Biol. 9, 257-263 (2013).
29. Liu, Y. et al. Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase. Sci. Transl. Med. 6, 266ra170 (2014).
30. Asimaki, A. et al. Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy. Sci. Transl. Med. 6, 240ra274 (2014).
31. Shin, J. T., Pomerantsev, E. V., Mably, J. D. & MacRae, C. A. High-resolution cardiovascular function confirms functional orthology of myocardial contractility pathways in zebrafish. Physiol. Genom. 42, 300-309 (2010).
32. Eliceiri, B. P., Gonzalez, A. M. & Baird, A. Zebrafish model of the blood-brain barrier: morphological and permeability studies. Methods Mol. Biol. 686, 371-378 (2011).
33. Fleming, A., Diekmann, H. & Goldsmith, P. Functional characterisation of the maturation of the blood-brain barrier in larval zebrafish. PLoS ONE 8, e77548 (2013).
34. Farber, S. A. et al. Genetic analysis of digestive physiology using fluorescent phospholipid reporters. Science 292, 1385-1388 (2001).
35. Popovic, M., Zaja, R., Fent, K. & Smital, T. Interaction of environmental contaminants with zebrafish organic anion transporting polypeptide, Oatp1d1 (Slco1d1). Toxicol. Appl. Pharmacol. 280, 149-158 (2014).
36. Chng, H. T., Ho, H. K., Yap, C. W., Lam, S. H. & Chan, E. C. An investigation of the bioactivation potential and metabolism profile of zebrafish versus human. J. Biomol. Screen. 17, 974-986 (2012).
37. Reimers, M. J., Flockton, A. R. & Tanguay, R. L. Ethanol-and acetaldehyde-mediated developmental toxicity in zebrafish. Neurotoxicol. Teratol. 26, 769-781 (2004).
38. Kluver, N. et al. Transient overexpression of adh8a increases allyl alcohol toxicity in zebrafish embryos. PLoS ONE 9, e90619 (2014).
39. Rennekamp, A. J. & Peterson, R. T. 15 years of zebrafish chemical screening. Curr. Opin. Chem. Biol. 24, 58-70 (2014).
40. North, T. E. et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 447, 1007-1011 (2007).
41. Goessling, W. et al. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 136, 1136-1147 (2009).
42. Cutler, C. et al. Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation. Blood 122, 3074-3081 (2013).
43. Hagedorn, E. J., Durand, E. M., Fast, E. M. & Zon, L. I. Getting more for your marrow: boosting hematopoietic stem cell numbers with PGE. Exp. Cell Res. 329, 220-226 (2014).
44. Yu, P. B. et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat. Chem. Biol. 4, 33-41 (2008).
45. Cuny, G. D. et al. Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. Bioorg. Med. Chem. Lett. 18, 4388-4392 (2008).
46. Theurl, I. et al. Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats. Blood 118, 4977-4984 (2011).
47. Derwall, M. et al. Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 32, 613-622 (2012).
48. Saeed, O. et al. Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 32, 299-307 (2012).
49. Wang, L. et al. The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease. Inflamm. Bowel Dis. 18, 112-119 (2012).
50. Owens, K. N. et al. Identification of genetic and chemical modulators of zebrafish mechanosensory hair cell death. PLoS Genet. 4, e1000020 (2008).
51. Yeh, J. R. et al. AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression. Development 135, 401-410 (2008).
52. Yeh, J. R. et al. Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation. Nat. Chem. Biol. 5, 236-243 (2009).
53. Wang, Y. et al. The Wnt/β-catenin pathway is required for the development of leukemia stem cells in AML. Science 327, 1650-1653 (2010).
54. Klimek, V. M., Dolezal, E. K., Smith, L., Soff, G. & Nimer, S. D. Phase I trial of sodium salicylate in patients with myelodysplastic syndromes and acute myelogenous leukemia. Leuk. Res. 36, 570-574 (2012).
55. Peal, D. S. et al. Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen. Circulation 123, 23-30 (2011).
56. Ziegler, S., Pries, V., Hedberg, C. & Waldmann, H. Target identification for small bioactive molecules: finding the needle in the haystack. Angew. Chem. Int. Ed Engl. 52, 2744-2792 (2013).
57. Gutierrez, A. et al. Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia. J. Clin. Invest. 124, 644-655 (2014).
58. Sandoval, I. T. et al. Juxtaposition of chemical and mutation-induced developmental defects in zebrafish reveal a copper-chelating activity for kalihinol F. Chem. Biol. 20, 753-763 (2013).
59. Zhang, Y. et al. A chemical and genetic approach to the mode of action of fumagillin. Chem. Biol. 13, 1001-1009 (2006).
60. Driessen, M. et al. A transcriptomics-based hepatotoxicity comparison between the zebrafish embryo and established human and rodent in vitro and in vivo models using cyclosporine A, amiodarone and acetaminophen. Toxicol. Lett. 232, 403-412 (2014).
61. Ducharme, N. A., Reif, D. M., Gustafsson, J. A. & Bondesson, M. Comparison of toxicity values across zebrafish early life stages and mammalian studies: implications for chemical testing. Reprod. Toxicol. 55, 3-10 (2014).
62. Hwang, W. Y. et al. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat. Biotech. 31, 227-229 (2013).
63. Gonzales, A. P. & Yeh, J. R. Cas9-based genome editing in zebrafish. Methods Enzymol. 546, 377-413 (2014).
64. Irion, U., Krauss, J. & Nusslein-Volhard, C. Precise and efficient genome editing in zebrafish using the CRISPR/Cas9 system. Development 141, 4827-4830 (2014).
65. Gagnon, J. A. et al. Efficient mutagenesis by Cas9 protein-mediated oligonucleotide insertion and large-scale assessment of single-guide RNAs. PLoS ONE 9, e98186 (2014).
66. Auer, T. O., Duroure, K., De Cian, A., Concordet, J. P. & Del Bene, F. Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair. Genome Res. 24, 142-153 (2014).
67. Xiao, A. et al. Chromosomal deletions and inversions mediated by TALENs and CRISPR/Cas in zebrafish. Nucleic Acids Res. 41, e141 (2013).
68. Peterson, R. T. et al. Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat. Biotech. 22, 595-599 (2004).
69. Stern, H. M. et al. Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nat. Chem. Biol. 1, 366-370 (2005).
70. Cao, Y. et al. Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models. Proc. Natl Acad. Sci. USA 106, 21819-21824 (2009).
71. Baraban, S. C., Dinday, M. T. & Hortopan, G. A. Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment. Nat. Commun. 4, 2410 (2013).
72. Rihel, J. et al. Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 327, 348-351 (2010).
73. Kokel, D. et al. Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat. Chem. Biol. 6, 231-237 (2010).
74. Wolman, M. A., Jain, R. A., Liss, L. & Granato, M. Chemical modulation of memory formation in larval zebrafish. Proc. Natl Acad. Sci. USA 108, 15468-15473 (2011).
75. Morris, J. A. Zebrafish: a model system to examine the neurodevelopmental basis of schizophrenia. Prog. Brain Res. 179, 97-106 (2009).
76. Singh, K. K. et al. Common DISC1 polymorphisms disrupt Wnt/GSK3β signaling and brain development. Neuron 72, 545-558 (2011).
77. Mathew, L. K. et al. Unraveling tissue regeneration pathways using chemical genetics. J. Biol. Chem. 282, 35202-35210 (2007).
78. Tran, T. C. et al. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish. Cancer Res. 67, 11386-11392 (2007).
79. Molina, G. et al. Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages. Nat. Chem. Biol. 5, 680-687 (2009).
80. Clifton, J. D. et al. Identification of novel inhibitors of dietary lipid absorption using zebrafish. PLoS ONE 5, e12386 (2010).
81. Ishizaki, H. et al. Combined zebrafish-yeast chemical-genetic screens reveal gene-copper-nutrition interactions that modulate melanocyte pigmentation. Dis. Model. Mech. 3, 639-651 (2010).
82. Wang, C. et al. Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer. Eur. Urol. 58, 418-426 (2010).
83. White, R. M. et al. DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature 471, 518-522 (2011).
84. Saydmohammed, M., Vollmer, L. L., Onuoha, E. O., Vogt, A. & Tsang, M. A high-content screening assay in transgenic zebrafish identifies two novel activators of fgf signaling. Birth Defects Res. C Embryo Today 93, 281-287 (2011).
85. Rovira, M. et al. Chemical screen identifies FDA-approved drugs and target pathways that induce precocious pancreatic endocrine differentiation. Proc. Natl Acad. Sci. USA 108, 19264-19269 (2011).
86. Colanesi, S. et al. Small molecule screening identifies targetable zebrafish pigmentation pathways. Pigment Cell. Melanoma Res. 25, 131-143 (2012).
87. Namdaran, P., Reinhart, K. E., Owens, K. N., Raible, D. W. & Rubel, E. W. Identification of modulators of hair cell regeneration in the zebrafish lateral line. J. Neurosci. 32, 3516-3528 (2012).
88. Becker, J. R. et al. In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling. Cardiovasc. Res. 93, 463-470 (2012).
89. Padilla, S. et al. Zebrafish developmental screening of the ToxCast Phase I chemical library. Reprod. Toxicol. 33, 174-187 (2012).
90. Ridges, S. et al. Zebrafish screen identifies novel compound with selective toxicity against leukemia. Blood 119, 5621-5631 (2012).
91. Weger, B. D., Weger, M., Nusser, M., Brenner-Weiss, G. & Dickmeis, T. A chemical screening system for glucocorticoid stress hormone signaling in an intact vertebrate. ACS Chem. Biol. 7, 1178-1183 (2012).
92. Jin, S. et al. An in vivo zebrafish screen identifies organophosphate antidotes with diverse mechanisms of action. J. Biomol. Screen 18, 108-115 (2013).
93. Nath, A. K. et al. Chemical and metabolomic screens identify novel biomarkers and antidotes for cyanide exposure. FASEB J. 27, 1928-1938 (2013).
94. Liu, Y. J. et al. Cannabinoid receptor 2 suppresses leukocyte inflammatory migration by modulating the JNK/c-Jun/Alox5 pathway. J. Biol. Chem. 288, 13551-13562 (2013).
95. Le, X. et al. A novel chemical screening strategy in zebrafish identifies common pathways in embryogenesis and rhabdomyosarcoma development. Development 140, 2354-2364 (2013).
96. Hao, J. et al. Selective small molecule targeting β-catenin function discovered by in vivo chemical genetic screen. Cell Rep. 4, 898-904 (2013).
97. Gebruers, E. et al. A phenotypic screen in zebrafish identifies a novel small-molecule inducer of ectopic tail formation suggestive of alterations in non-canonical Wnt/PCP signaling. PLoS ONE 8, e83293 (2013).
98. Kong, Y. et al. Neural crest development and craniofacial morphogenesis is coordinated by nitric oxide and histone acetylation. Chem. Biol. 21, 488-501 (2014).
99. Nishiya, N. et al. A zebrafish chemical suppressor screening identifies small molecule inhibitors of the Wnt/β-catenin pathway. Chem. Biol. 21, 530-540 (2014).
100. Tsuji, N. et al. Whole organism high content screening identifies stimulators of pancreatic β-cell proliferation. PLoS ONE 9, e104112 (2014).
101. Nath, A. K. et al. PTPMT1 inhibition lowers glucose through succinate dehydrogenase phosphorylation. Cell Rep. 10, 694-701 (2015).
102. Williams, C. H. et al. An in vivo chemical genetic screen identifies phosphodiesterase 4 as a pharmacological target for Hedgehog signaling inhibition. Cell Rep. 11, 43-50 (2015).
103. Gallardo, V. E. et al. Phenotype-driven chemical screening in zebrafish for compounds that inhibit collective cell migration identifies multiple pathways potentially involved in metastatic invasion. Dis. Model. Mech. 8, 565-576 (2015).
104. Evanson, K. J. et al. Identification of chemical inhibitors of β-catenin-driven liver tumorigenesis in zebrafish. PLoS Genet.11, e1005305 (2015).
105. Li, P. et al. Epoxyeicosatrienoic acids enhance embryonic haematopoiesis and adult marrow engraftment. Nature 523, 468-471 (2015).
106. Wang, G. et al. First quantitative high-throughput screen in zebrafish identifies novel pathways for increasing pancreatic β-cell mass. eLife. 4, e08261 (2015).